Evidence map›Paper›PMID 39867051›Full record

ArticleCureus2024

Antimicrobial Resistance Patterns of Clinically Isolated Strains of Acinetobacter baumannii in a Tertiary Care Hospital in Libya.

Dalal Thwood, Zynab Alghadem, Nada Elgriw, Maren Hnaya, Ahmed Zaghdani, Salah Edin El Meshri, Adem Elzagheid

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dalal ThwoodDepartment of Microbiology, Libyan Biotechnology Research Center, Tripoli, LBY.
Zynab AlghademDepartment of Microbiology, Libyan Biotechnology Research Center, Tripoli, LBY.
Nada ElgriwDepartment of Microbiology, Libyan Biotechnology Research Center, Tripoli, LBY.
Maren HnayaDepartment of Microbiology, Tripoli University Hospital, Tripoli, LBY.
Ahmed ZaghdaniDepartment of Microbiology, Libyan Biotechnology Research Center, Tripoli, LBY.
Salah Edin El MeshriDepartment of Microbiology, Libyan Biotechnology Research Center, Tripoli, LBY.
Adem ElzagheidDepartment of Genetic Engineering, Libyan Biotechnology Research Center, Tripoli, LBY.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMATERIALS AND

methodsThis retrospective cross-sectional study was carried out in the Department of Microbiology at TUH in Libya from January 2021 to June 2021. Identification of isolates was performed using the VITEK® 2 automated system (bioMérieux, France), and the isolates were categorized as susceptible, intermediate susceptible, or resistant according to the minimum inhibitory concentration (MIC).

resultsA total of 86

conclusionThese findings prompt clinicians to consider taking minocycline and amikacin into account when starting empirical therapy for severe infections caused by

Indexed as

acinetobacter baumanniiantibiogramantimicrobial resistanceclinical specimensmdrab

Identifiers

PMID39867051
PMCPMC11769699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.